AOP Orphan Wants Remnants Of €142M Award OK'd In Mass.
Although a German court ruled to set aside a €142 million ($161.8 million) arbitral award issued to Austrian pharmaceutical company AOP Orphan last month, the Austrian company and the Taiwanese drug...To view the full article, register now.
Already a subscriber? Click here to view full article